GO:0055003 cardiac myofibril assembly: Sarcomere Assembly Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055003 cardiac myofibril assembly describes the progression of a cardiac myofibril from formation to mature structure, a process specific to cardiac muscle cells.
• The process is driven by the stepwise assembly of sarcomeric proteins including titin, alpha-actinin, tropomyosin, and CMYA5 into organized contractile units.
• Key regulators include Cypher/ZASP, which drives cardiomyocyte maturation via actin-mediated MRTFA-SRF signalling, and RBPMS/RBPMS2, which safeguard cardiac splicing.
• Disruption of cardiac myofibril assembly is linked to cardiomyopathy, heart failure, and embryonic lethality, making it a critical area for cardiovascular research.
• Research methods include cultured neonatal cardiomyocyte models, live imaging of sarcomere assembly, and CRISPR-based gene editing to test causal roles.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to accelerate cardiac myofibril assembly research.
Description
Cardiac myofibril assembly (GO:0055003) is the biological process by which cardiac muscle cells build their contractile apparatus, progressing from initial protein assembly to a mature myofibril structure. This process is fundamental to heart development and function, as the myofibril is the basic contractile unit of cardiomyocytes. Understanding the molecular players and regulatory mechanisms of cardiac myofibril assembly is essential for uncovering the causes of congenital heart defects and cardiomyopathies. The assembly process involves the coordinated incorporation of sarcomeric proteins such as titin, alpha-actinin, and tropomyosin into organized sarcomeres. Recent studies have identified novel regulators like CMYA5, which enhances the assembly of cardiac dyads, and Cypher/ZASP, which drives cardiomyocyte maturation through actin-mediated signalling. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of cardiac myofibril assembly, its key genes, regulatory mechanisms, disease relevance, and research methodologies.
cardiac myofibril assembly At A Glance
| GO ID | GO:0055003 |
|---|---|
| GO term | cardiac myofibril assembly |
| Ontology | biological_process |
| Synonym | cardiac myofibril development; cardiac myofibril morphogenesis; heart myofibril assembly |
| Major function | Assembly and maturation of the cardiac myofibril, the contractile unit of cardiomyocytes |
| Cellular location | Cardiac muscle cell cytoplasm, sarcomere |
| Key proteins | Titin, alpha-actinin, tropomyosin, CMYA5, Cypher/ZASP |
| Related processes | Cardiomyocyte maturation, sarcomere organization, heart morphogenesis |
What Is GO:0055003?
Cardiac myofibril assembly is the biological process whose specific outcome is the progression of the cardiac myofibril over time, from its formation to the mature structure. A cardiac myofibril is a myofibril specific to cardiac muscle cells. This process encompasses the initial assembly of sarcomeric proteins into premyofibrils, their maturation into mature myofibrils, and the maintenance of the contractile apparatus.
Why Is cardiac myofibril assembly Important in Cell Biology?
Cardiac myofibril assembly is essential for the development and function of the heart, as it directly underlies the contractile capacity of cardiomyocytes. Defects in this process lead to severe cardiac pathologies, including dilated cardiomyopathy, hypertrophic cardiomyopathy, and congenital heart defects. Understanding the molecular mechanisms of cardiac myofibril assembly provides insights into heart disease pathogenesis and identifies potential therapeutic targets.
• Critical for heart development and function, as myofibrils are the contractile units of cardiomyocytes.
• Disruption leads to embryonic lethality and cardiac malformations in animal models.
• Mutations in sarcomeric proteins cause inherited cardiomyopathies.
• Key process for cardiomyocyte maturation, relevant to regenerative medicine and stem cell-derived cardiomyocytes.
• Involved in cardiac hypertrophy and heart failure signaling.
• Provides targets for gene therapy approaches to enhance cardiac repair.
• Essential for understanding actin cytoskeleton dynamics in muscle cells.
• Splicing regulators like RBPMS/RBPMS2 are critical for proper myofibril assembly.
• Tropomyosin is required for cardiac morphogenesis and adherens junction formation.
• Cultured neonatal cardiomyocytes serve as a tractable model to study myofibril assembly.
What Happens During cardiac myofibril assembly?
Initiation and premyofibril formation
In simple terms: Cardiac muscle cells start building their contraction machinery by assembling early protein structures called premyofibrils.
Cardiac myofibril assembly begins with the formation of premyofibrils, which are immature contractile structures containing sarcomeric proteins such as actin, myosin, and titin. Titin ligands play functional roles in this initial assembly and in the maintenance of cardiac myofibrils. Alpha-actinin-1 promotes adhesion maturation and facilitates sarcomere assembly in cardiac myocytes, acting as a key early organizer.
Sarcomere organization and maturation
In simple terms: The early structures mature into organized sarcomeres, the repeating units that make heart muscle contract.
During maturation, premyofibrils transition into mature myofibrils with well-defined sarcomeric bands. Tropomyosin is required for cardiac morphogenesis, myofibril assembly, and formation of adherens junctions in the developing mouse embryo. Cypher/ZASP drives cardiomyocyte maturation via actin-mediated MRTFA-SRF signalling, linking cytoskeletal dynamics to transcriptional programs.
Role of CMYA5 in cardiac dyad assembly
In simple terms: A protein called CMYA5 helps assemble specialized structures that connect the contractile machinery to calcium signaling hubs.
Virally delivered CMYA5 enhances the assembly of cardiac dyads, specialized junctions between the sarcolemma and sarcoplasmic reticulum that are essential for excitation-contraction coupling. This highlights the interplay between myofibril assembly and calcium handling machinery.
Splicing regulation and quality control
In simple terms: Proper RNA processing ensures that the right protein building blocks are made for the heart muscle.
RBPMS and RBPMS2 cooperate to safeguard cardiac splicing, ensuring correct isoform expression of sarcomeric genes required for myofibril assembly. Disruption of splicing regulation leads to defective myofibril formation and cardiac dysfunction.
Maintenance and remodeling
In simple terms: Even after the heart muscle is built, the contraction machinery is constantly maintained and remodeled.
Cardiac myofibril assembly is not a one-time event; titin ligands are involved in both assembly and maintenance of cardiac myofibrils. In cultured mouse neonatal cardiomyocytes, myofibril assembly can be observed dynamically, providing a model for studying maintenance and remodeling.
Key Genes Involved in GO:0055003 cardiac myofibril assembly
The following genes and proteins are central to cardiac myofibril assembly, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TTN (Titin) | Scaffold protein for sarcomere assembly and maintenance | Titin ligands are critical for cardiac myofibril assembly and maintenance |
| ACTN1 (Alpha-actinin-1) | Crosslinks actin filaments, promotes adhesion maturation | Facilitates sarcomere assembly in cardiac myocytes |
| TPM1 (Tropomyosin) | Regulates actin-myosin interaction, required for myofibril assembly | Tropomyosin is required for cardiac morphogenesis and myofibril assembly |
| CMYA5 (Myospryn) | Enhances assembly of cardiac dyads | Virally delivered CMYA5 enhances cardiac dyad assembly |
| Cypher/ZASP (LDB3) | Drives cardiomyocyte maturation via actin-mediated MRTFA-SRF signalling | Cypher/ZASP is essential for cardiomyocyte maturation |
| RBPMS | Safeguards cardiac splicing | Cooperates with RBPMS2 to ensure proper splicing of sarcomeric genes |
| RBPMS2 | Safeguards cardiac splicing | Cooperates with RBPMS to ensure proper splicing of sarcomeric genes |
| MYH7 (Myosin heavy chain 7) | Motor protein for muscle contraction | Mutations cause hypertrophic cardiomyopathy; assembly requires myosin incorporation |
| ACTC1 (Cardiac actin) | Main component of thin filaments | Actin dynamics are central to myofibril assembly |
| MYBPC3 (Myosin binding protein C) | Regulates myosin function | Mutations linked to cardiomyopathy; involved in sarcomere assembly |
| TNNT2 (Troponin T) | Regulates calcium-dependent contraction | Mutations cause cardiomyopathy; part of the sarcomere |
| DES (Desmin) | Intermediate filament protein, links sarcomeres | Important for myofibril integrity and assembly |
| MRTFA (Myocardin-related transcription factor A) | Transcription factor downstream of actin signaling | Mediates Cypher/ZASP-driven cardiomyocyte maturation |
| SRF (Serum response factor) | Transcription factor regulating muscle genes | Part of MRTFA-SRF signalling in cardiomyocyte maturation |
| FLNC (Filamin C) | Actin-crosslinking protein in muscle | Mutations cause cardiomyopathy; involved in sarcomere assembly |
| BAG3 | Co-chaperone for protein quality control | Mutations cause cardiomyopathy; supports myofibril maintenance |
| TCAP (Telethonin) | Titin-binding protein | Mutations cause cardiomyopathy; involved in sarcomere assembly |
How Is cardiac myofibril assembly Regulated?
Cardiac myofibril assembly is regulated at multiple levels, including transcriptional control by MRTFA-SRF signalling downstream of Cypher/ZASP, and post-transcriptional regulation by splicing factors RBPMS and RBPMS2. Additionally, the process is influenced by actin cytoskeleton dynamics, as alpha-actinin-1 promotes adhesion maturation and facilitates sarcomere assembly. Tropomyosin is required for cardiac morphogenesis and myofibril assembly, indicating its regulatory role in actin filament stabilization.
cardiac myofibril assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TTN | Dilated cardiomyopathy, titinopathies | Knockout or point-mutation in iPSC-derived cardiomyocytes |
| ACTN1 | Cardiomyopathy, adhesion defects | Knockout in neonatal cardiomyocytes |
| TPM1 | Hypertrophic cardiomyopathy, congenital heart defects | Knockout mouse model or CRISPR-edited cardiomyocytes |
| LDB3 (Cypher/ZASP) | Dilated cardiomyopathy, left ventricular noncompaction | Knockout or overexpression in cardiomyocytes |
| RBPMS/RBPMS2 | Cardiac splicing defects, heart failure | Double knockout in mouse models or iPSC-derived cardiomyocytes |
Cardiomyopathies
Mutations in genes encoding sarcomeric proteins such as titin, alpha-actinin, tropomyosin, and Cypher/ZASP lead to dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy. Defective cardiac myofibril assembly is a common pathogenic mechanism underlying these inherited heart diseases.
Congenital heart defects
Disruption of cardiac myofibril assembly during embryonic development causes congenital heart defects and embryonic lethality, as shown in mouse models with tropomyosin deficiency. Proper myofibril assembly is essential for heart morphogenesis.
Heart failure and remodeling
Impaired myofibril maintenance and remodeling contribute to heart failure progression. Cypher/ZASP-driven cardiomyocyte maturation pathways are dysregulated in heart failure, and targeting these pathways may offer therapeutic benefits.
Splicing-related cardiac disorders
Defects in RBPMS/RBPMS2-mediated splicing lead to aberrant sarcomeric gene expression and cardiac dysfunction, highlighting the importance of post-transcriptional regulation in myofibril assembly.
From cardiac myofibril assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate cardiac myofibril assembly? | CRISPR knockout in neonatal cardiomyocytes or iPSC-derived cardiomyocytes |
| Does a specific point mutation in a sarcomeric gene cause assembly defects? | Point-mutation knock-in via CRISPR in cardiomyocytes |
| Can a therapeutic protein enhance myofibril assembly? | Overexpression of CMYA5 or other candidates in cardiomyocytes |
| How does a gene affect cardiomyocyte maturation? | Knockout or overexpression of Cypher/ZASP in cardiomyocytes |
| What is the role of splicing factors in myofibril assembly? | Knockout of RBPMS/RBPMS2 in cardiac cells |
| How does tropomyosin contribute to myofibril assembly? | Tropomyosin knockout mouse embryos |
How to Study the cardiac myofibril assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Dynamics of sarcomere assembly | Visualizing premyofibril to myofibril transition |
| CRISPR knockout | Loss-of-function effects on myofibril assembly | Testing candidate gene necessity |
| CRISPR point mutation | Effect of specific disease-associated mutations | Modeling cardiomyopathy variants |
| Overexpression | Gain-of-function effects on assembly | Enhancing dyad assembly via CMYA5 |
| RNA-seq | Transcriptomic changes and splicing defects | Analyzing RBPMS/RBPMS2 targets |
| Proteomics | Protein interactions and complex composition | Identifying titin ligand networks |
| Immunofluorescence | Sarcomeric protein localization | Assessing myofibril integrity |
| Electron microscopy | Ultrastructure of sarcomeres | Validating mature myofibril formation |
Live-cell imaging of sarcomere assembly
Fluorescent tagging of sarcomeric proteins such as alpha-actinin or titin allows real-time visualization of myofibril assembly in cultured cardiomyocytes. This method reveals the dynamics of premyofibril formation and maturation.
CRISPR-based gene editing
Knockout, point mutation, and knock-in models generated by CRISPR/Cas9 enable causal testing of candidate genes in cardiac myofibril assembly. These models can be applied in iPSC-derived cardiomyocytes or animal models.
Transcriptomic and splicing analysis
RNA-seq and splicing assays can identify dysregulated sarcomeric gene isoforms upon perturbation of splicing factors like RBPMS/RBPMS2. This helps link splicing regulation to myofibril assembly defects.
Proteomic and interactome profiling
Mass spectrometry-based proteomics can identify protein complexes involved in myofibril assembly, such as titin ligands and CMYA5-associated dyad components. This provides a systems-level view of the assembly machinery.
How CRISPR Can Be Used to Study GO:0055003 cardiac myofibril assembly
Knockout
CRISPR knockout of genes such as ACTN1, TPM1, or LDB3 in cardiomyocytes can reveal their essential roles in cardiac myofibril assembly. Knockout models help determine whether a gene is required for premyofibril formation or maturation.
Point Mutation
Introducing disease-associated point mutations (e.g., in TTN or MYH7) via CRISPR base editing or HDR allows modeling of cardiomyopathies and assessing their impact on myofibril assembly. These models are valuable for drug screening and mechanistic studies.
Knock-in
Knock-in of fluorescent tags (e.g., GFP or mCherry) into endogenous sarcomeric genes enables live imaging of myofibril assembly dynamics. Tagged knock-in models can also be used to track protein localization and turnover.
Overexpression
CRISPR activation or lentiviral overexpression of CMYA5 or Cypher/ZASP can enhance cardiac dyad assembly and cardiomyocyte maturation. Overexpression models are useful for identifying sufficiency of a gene to drive assembly.
How EDITGENE Supports cardiac myofibril assembly Research
Researchers studying cardiac myofibril assembly-related genes often need to determine whether a candidate gene is causally involved in the assembly process, which requires precise genetic manipulation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for cardiac myofibril assembly research.
Frequently Asked Questions About cardiac myofibril assembly
What is cardiac myofibril assembly?
Cardiac myofibril assembly (GO:0055003) is the biological process by which cardiac muscle cells build their contractile apparatus, progressing from formation to a mature myofibril structure.
What genes are involved in cardiac myofibril assembly?
Key genes include TTN (titin), ACTN1 (alpha-actinin-1), TPM1 (tropomyosin), CMYA5, Cypher/ZASP (LDB3), RBPMS, and RBPMS2.
Why is cardiac myofibril assembly important?
It is essential for heart development and function; defects cause cardiomyopathies, congenital heart defects, and heart failure.
What are the stages of cardiac myofibril assembly?
The process includes premyofibril formation, sarcomere organization and maturation, dyad assembly, splicing regulation, and maintenance/remodeling.
How is cardiac myofibril assembly studied?
Common methods include live-cell imaging, CRISPR gene editing, RNA-seq, proteomics, immunofluorescence, and electron microscopy.
What diseases are linked to defective cardiac myofibril assembly?
Dilated cardiomyopathy, hypertrophic cardiomyopathy, congenital heart defects, and heart failure are linked to defects in this process.
What is the role of titin in cardiac myofibril assembly?
Titin acts as a scaffold protein and its ligands are critical for both assembly and maintenance of cardiac myofibrils.
How does Cypher/ZASP regulate cardiac myofibril assembly?
Cypher/ZASP drives cardiomyocyte maturation via actin-mediated MRTFA-SRF signalling, which is essential for proper myofibril assembly.
Can CRISPR be used to study cardiac myofibril assembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in cardiac myofibril assembly.
What models are available for cardiac myofibril assembly research?
Cultured mouse neonatal cardiomyocytes, iPSC-derived cardiomyocytes, and genetically modified mouse models are commonly used.
Conclusion
Cardiac myofibril assembly (GO:0055003) is a fundamental biological process required for heart development and function. The coordinated assembly of sarcomeric proteins, regulated by factors such as titin, alpha-actinin, tropomyosin, CMYA5, Cypher/ZASP, and RBPMS/RBPMS2, ensures proper contractile apparatus formation. Defects in this process lead to severe cardiac diseases, making it a critical area for cardiovascular research. Advances in CRISPR-based gene editing and imaging technologies continue to unravel the molecular mechanisms of cardiac myofibril assembly, offering hope for novel therapeutic strategies.
References
- 1. Lu F et al.. 2025. Virally delivered CMYA5 enhances the assembly of cardiac dyads.. Nat Biomed Eng 9(5):730-741 PMID: 39237710
- 2. McElhinny AS et al.. 2000. Probing the functional roles of titin ligands in cardiac myofibril assembly and maintenance.. Adv Exp Med Biol 481:67-86; discussion 86-8 PMID: 10987067
- 3. Lyu J et al.. 2024. Cypher/ZASP drives cardiomyocyte maturation via actin-mediated MRTFA-SRF signalling.. Theranostics 14(11):4462-4480 PMID: 39113806
- 4. Hayes JB et al.. 2025. Alpha-actinin-1 promotes adhesion maturation and facilitates sarcomere assembly in cardiac myocytes.. Mol Biol Cell 36(11):br27 PMID: 40928931
- 5. Gregorio CC et al.. 2000. To the heart of myofibril assembly.. Trends Cell Biol 10(9):355-62 PMID: 10932092
- 6. Wu T et al.. 2025. RBPMS and RBPMS2 Cooperate to Safeguard Cardiac Splicing.. Circ Res 137(7):1027-1044 PMID: 40859824
- 7. White J et al.. 2018. Myofibril Assembly in Cultured Mouse Neonatal Cardiomyocytes.. Anat Rec (Hoboken) 301(12):2067-2079 PMID: 30537042
- 8. McKeown CR et al.. 2014. Tropomyosin is required for cardiac morphogenesis, myofibril assembly, and formation of adherens junctions in the developing mouse embryo.. Dev Dyn 243(6):800-17 PMID: 24500875
